// App-Quantinova.ai

11040 : Targeted next-generation sequencing (NGS) of circulating tumor cells (CTCs) in hormone-sensitive prostate cancer (HSPC).

Researchers

Presenter

  • Stephen V. Liu

Principal Investigators

  • Paul W. Dempsey

  • William Strauss

  • Janine McMurdie

  • Amir Goldkorn

  • Yucheng Xu

  • Tong Xu

  • Jacek K. Pinski

  • Tanya B. Dorff

  • David I. Quinn

  • Timothy J. Triche

  • Jessamine Winer-Jones

  • Andre De Fusco

Medical Centers

  • Cynvenio Biosystems Inc, Westlake Village, CA

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • Life Technologies, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Epithelial Cell Adhesion Molecule

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved